These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7721404)

  • 1. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
    Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR
    Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
    Schmitt F; Martinez F; Brillet G; Nguyen-Khoa T; Brouard R; Sissmann J; Lacour B; Grunfeld JP
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):314-21. PubMed ID: 9475275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
    Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
    Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men.
    McIntyre M; MacFadyen RJ; Meredith PA; Brouard R; Reid JL
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):101-6. PubMed ID: 8797143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men.
    Ribstein J; Picard A; Armagnac C; Sissmann J; Mimran A
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
    Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner HR
    Am J Kidney Dis; 1995 Jul; 26(1):108-15. PubMed ID: 7611241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
    Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
    Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions.
    Fliser D; Dikow R; Demukaj S; Ritz E
    J Am Soc Nephrol; 2000 Nov; 11(11):2001-2006. PubMed ID: 11053475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension.
    van den Meiracker AH; Admiraal PJ; Janssen JA; Kroodsma JM; de Ronde WA; Boomsma F; Sissmann J; Blankestijn PJ; Mulder PG; Man In 't Veld AJ
    Hypertension; 1995 Jan; 25(1):22-9. PubMed ID: 7843749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
    Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
    Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
    Cervenka L; Wang CT; Navar LG
    Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.
    Gandhi SK; Ryder DH; Brown NJ
    Hypertension; 1996 Dec; 28(6):961-6. PubMed ID: 8952583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner HR; Burnier M
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.
    Rossi GP; Sacchetto A; Rizzoni D; Bova S; Porteri E; Mazzocchi G; Belloni AS; Bahcelioglu M; Nussdorfer GG; Pessina AC
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):949-56. PubMed ID: 10764658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.